Amgen will team up with Watson Pharmaceuticals to develop and commercialize follow-on versions of several antibody biotech drugs for cancer, excluding Amgen's products. Amgen will be in charge of development, production and initial marketing. Watson will provide as much as $400 million for product development and contribute its commercialization and marketing know-how.

Related Summaries